A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage-Reference-Cited by-同舟云学术

A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage

Published:2020-02 Issue:1 Volume:2 Page:100064
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Segal-Salto Michal,Barashi Neta,Katav Avi,Edelshtein Vicktoria,Aharon Arnon,Hashmueli Sharon,George Jacob,Maor Yaakov,Pinzani Massimo,Haberman Dan,Hall Andrew,Friedman Scott,Mor Adi

Funder

ChemomAb Ltd

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference45 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases;Chalasani;Hepatology,2018

2. Pharmacotherapy for NASH: current and emerging;Konerman;J Hepatol,2018

3. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat Med,2018

4. Mechanisms of hepatic fibrogenesis;Friedman;Gastroenterology,2008

5. Hepatic fibrosis: emerging therapies;Friedman;Dig Dis,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-derived CCL24 promotes fibrosis and worsens cardiac dysfunction during heart failure;2024-07-16

2. Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies;Drug Safety;2024-06-01

3. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis;Expert Opinion on Pharmacotherapy;2024-05-02

4. Inflammatory responses in esophageal mucosa before and after laparoscopic antireflux surgery;World Journal of Gastrointestinal Surgery;2024-03-27

5. Mechanosensing regulates tissue repair program in macrophages;Science Advances;2024-03-15